Today's Healthcare Pulse
Pharma Shifts Ad Spend to Spot TV Amid Heightened FDA Scrutiny
Pharmaceutical advertisers are redirecting dollars toward spot television placements as the FDA intensifies its oversight of drug marketing. The trend reflects a strategic move to capture audiences with shorter, targeted ads while navigating tighter regulatory expectations.
Also developing:
By the numbers: Apogee Therapeutics secures $1.3B royalty financing
Oruka Reports Positive Data From Phase IIa Trial for Plaque Psoriasis
Oruka Therapeutics announced interim results from its EVERLAST‑A Phase IIa trial of ORKA‑001, a half‑life‑extended IL‑23p19 monoclonal antibody, in moderate‑to‑severe plaque psoriasis. Of the 63 patients receiving the 600 mg dose, 63.5% achieved PASI 100 by week 16, meeting the primary endpoint, with 83% reaching PASI 90 as a secondary measure. Safety was favorable, showing no serious treatment‑emergent adverse events and a comparable adverse‑event profile to placebo. The company plans to release longer‑term data in late 2026 and advance the Phase IIb EVERLAST‑B trial for 2027.
Blackpool Teaching Hospitals Goes Live with eObservations and Bleep System Replacement
Blackpool Teaching Hospitals NHS Foundation Trust has gone live with eObservations in its emergency department, enabling clinicians to capture vital signs on iPads and view results instantly. At the same time, the trust replaced its ageing bleep system with Alertive,...
Radiation Oncologists Converge on Capitol Hill to Push for Payment Reform
Radiation oncologists gathered on Capitol Hill for ASTRO's annual advocacy day, urging Congress to pass the Radiation Oncology Case Rate Act. A recent ASTRO survey shows two‑thirds of specialists have seen pay cuts of 10% or more since the start...
Dehaze Raises €3.2M for AI Chronic Disease Detection
Munich‑based healthtech startup dehaze announced a €3.2 million (≈$3.5 million) seed round. The round was led by YZR Capital and DN Capital with participation from Angel Invest, Zoho and Better Ventures. dehaze will use the capital to build a foundational causal AI...
Novartis CEO Warns Reality of Trump's Drug Pricing Policy Will Set in over 'the Next 18 Months'
Novartis chief executive Vas Narasimhan warned that President Donald Trump’s most‑favored‑nation (MFN) drug‑pricing rule will fully materialize within the next 18 months, tying U.S. prices to those in affluent foreign markets. The policy currently touches only 5‑10% of Novartis’s Medicaid sales...
Dr. Oliver Kharraz on the Decades-Long Journey to Make Scheduling a Doctor's Appointment Easier
In this episode, Christina Farr talks with Oliver Kharraz, CEO of Zocdoc, about the 15‑year quest to simplify doctor appointment scheduling. Kharraz explains how hidden appointment inventory and last‑minute cancellations can be leveraged as a matchmaking clearinghouse, and recounts early...
An Octopus Probe for High-Performance >1,300 Nm NIR-II Fluorescence Molecular Imaging of Cancer
Researchers at Stanford introduced the Octopus (OCTP) probe, a modular NIR‑II fluorescence agent that emits beyond 1,300 nm and targets the folate receptor. In pre‑clinical mouse studies, OCTP delivered markedly higher tumor‑to‑background ratios and brighter tumor signals than the FDA‑approved Cytalux...
Enhanced Mechanical Strength and Controlled Degradation of PLA/ZnO Nanoparticle Composites for Biodegradable Implants
Researchers have engineered polylactic acid (PLA) composites reinforced with zinc oxide (ZnO) nanoparticles in two morphologies—nanospheres and nanorods—to create biodegradable implant materials. Tensile testing revealed that PLA/ZnO nanosphere composites reach 25.20 MPa, outperforming the nanorod variant at 22.98 MPa. Incorporating ZnO accelerated...
Re: Effectiveness of Interventions to Increase Vaccine Uptake: Component Network Meta-Analysis
Sunil Raina’s letter argues that trust, not logistics, is the core driver of vaccine uptake. He critiques the BMJ meta‑analysis for focusing on behavioral nudges while overlooking why people resist vaccines. The response highlights how reminders, community‑member involvement, and financial...
HKUST's New Complex Boosts Doctor Training, Global Medical Hub
Chief Executive John Lee, at the groundbreaking ceremony for HKUST's new medical education and research complex: • will increase local doctor training, easing manpower shortages • will help meet challenges of an aging population • Hong Kong is fast emerging as...
Measles Misinfo Meets Political Insults in Vaccine Debate
I just said that the children in our family already had measles and it was measly and a breeze, and they have lifetime immunity and proven protection against certain cancers. You claimed to be Maga and shame people who don’t...
Why ‘Wound Closure’ Is The Wrong Metric for Trauma Surgery
The article argues that wound closure is an outdated success metric for trauma surgery, emphasizing that true recovery hinges on functional, aesthetic, and quality‑of‑life outcomes. It highlights regenerative technologies—autologous cell systems and dermal scaffolds—that deliver superior skin regeneration, reduce donor‑site...
Efforts to Eliminate Hepatitis Delivers Gains but More Action Needed to Meet 2030 Targets
The WHO’s 2026 Global Hepatitis Report shows progress since 2015, with a 32% drop in new hepatitis B infections and a 12% decline in hepatitis C deaths. Yet hepatitis B and C still caused 1.34 million deaths in 2024 and new...
Vitamin D Boosts Breast Cancer Treatment Success by 79%
Researchers at São Paulo State University conducted a randomized trial of 80 women over 45 undergoing neoadjuvant chemotherapy for breast cancer. One half received 2,000 IU of vitamin D daily, while the other took a placebo. After six months, 43% of the...
Viewpoint: Medical MJ Resked: Implications for Insurance Coverage, Capacity and Compliance
On April 23 the Department of Justice re‑classified state‑licensed medical marijuana and FDA‑approved cannabis products to Schedule III, easing the federal tax penalty under IRC 280E. The change removes a major financial headwind, improving margins for operators and opening the door for broader...
AI Predicts Surgery Risks, Cuts Postoperative Deaths
What could we expect from AI in surgery? TIME magazine has an article on 4 concrete examples and the lowest-hanging fruit. As more than 4 million people die within a month of surgery every year, postoperative mortality is the first example: "𝐴𝑙𝑔𝑜𝑟𝑖𝑡ℎ𝑚𝑠 𝑐𝑎𝑛 𝑛𝑜𝑤...
How Pediatricians Are Navigating America’s Surge of Health Misinformation
Pediatricians across the United States are confronting a sharp rise in vaccine misinformation that has been amplified by the Covid‑19 pandemic and high‑profile political figures. Anti‑vaccine sentiment, once marginal, now enjoys mainstream visibility, with Health Secretary Robert F. Kennedy Jr....
Tracking Health in Autistic Adults, and More
Two recent peer‑reviewed studies reveal that autistic adults experience markedly higher rates of type 2 diabetes, hypertension, obesity and inflammatory bowel disease, and that mortality is significantly greater for individuals diagnosed with autism in childhood compared with matched non‑autistic peers. The...
Why Healthcare AI Still Can’t Scale — and How Nvidia & Hoppr Are Trying to Fix It
Healthcare AI adoption is hampered by deployment and scaling challenges, prompting Nvidia and Hoppr to pivot from building standalone models to creating an AI foundry infrastructure. The foundry leverages Nvidia’s computing power and pre‑trained foundation models, allowing hospitals and radiology...
TB‑500 Is Not TB‑4: No Human Evidence
TB - 500 is a short chain fragment synthesized from Thymosin Beta-4. TB-4 has solid human evidence for use. TB500 has absolutely no evidence. Totally different compounds. They cannot be referred to interchangeably because they simply are NOT the same
428. I Have Arranged to Get You Unbekoming's Complete New DMSO Book for Free.
The author of Surviving Healthcare has secured a free PDF of Unbekoming’s comprehensive DMSO book and is distributing it to his readership. Unbekoming, an Australian Substack writer, normally locks the 15‑book health library behind a paid subscription, but a limited‑time...
How Personalizing Nutrition Can Manage Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) affects roughly 2.4‑3.1 million Americans and costs the U.S. economy about $50 billion each year. New research highlights that the typical Western diet—rich in refined sugars, vegetable oils, and ultra‑processed foods—disrupts the gut microbiome, increases intestinal permeability, and...
CMS Unveils Proposed 2028 HCBS Quality Measure Set: What It Means For Home Care Providers
The Centers for Medicare & Medicaid Services (CMS) has released a proposed set of 23 mandatory quality measures for Medicaid home‑ and community‑based services (HCBS) slated for 2028. The measures, which emphasize person‑centered outcomes such as safety, respect, and community...
Today’s Neurology Science Briefing
A recent BMJ Neurology brief highlights robust evidence that subthalamic deep brain stimulation (DBS) offers measurable motor benefits for patients with symmetric Parkinson's disease, giving clinicians clearer risk‑benefit guidance. The study’s real‑world data strengthens counseling on DBS candidacy and expected...
AES Cleanroom Technology Appoints John Groth as CRO to Drive Growth
AES Cleanroom Technology announced the appointment of John Groth as Chief Revenue Officer. Groth, who brings more than two decades of pharma manufacturing and capital‑equipment sales experience, will lead revenue‑generating functions as the company expands its modular cleanroom solutions for...
Intellia Files FDA BLA After Phase 3 Shows 87% Cut in HAE Attacks
Intellia Therapeutics announced a rolling biologics license application to the FDA after its Phase 3 HAELO trial demonstrated an 87% reduction in hereditary angioedema attacks with a single dose of lonvo‑z. The results, the first from an in‑vivo CRISPR therapy, could...
CMS Extends Medicare GLP‑1 Bridge Program, Keeping $50 Copay for Obesity Drugs Through 2027
The Centers for Medicare & Medicaid Services (CMS) announced that the Medicare GLP‑1 Bridge program, which offers obesity drugs at a $50 copay, will now run through the end of 2027 instead of ending in December 2026. The extension delays...
Today’s Public Health Science Briefing
Recent research published in The Lancet Diabetes & Endocrinology finds that men with diabetes who maintain low levels of visceral fat face a markedly lower risk of developing diabetic kidney disease. The study highlights that relying solely on Body Mass...
Janux Therapeutics Halts Development of EGFR‑Targeted TRACTr Candidate JANX008
Janux Therapeutics announced it will cease clinical development of JANX008, its EGFR‑targeted Tumor‑Activated T Cell Engager, after completing Phase 1a. The company said the data did not meet predefined activity thresholds, prompting a reallocation of resources to other TRACTr pipeline assets....
Breakthrough Prize Showcases Baby Gene‑Editing Miracle
The 2026 Breakthrough Prize ceremony (“the Oscars for science”) celebrated the achievements of many remarkable scientists and their students and collaborators last weekend. Here’s the video of the show: https://t.co/eCHUnDqrYX. And here’s the segment in which Anne Hathaway and Alex...
True, OYMotion Pioneer Neuro AI Technology
True Corporation’s Research and Innovation Centre has teamed with neuro‑tech firm OYMotion to create a neuro‑AI platform that translates brain signals into commands for smart devices and prosthetics, aiming to accelerate rehabilitation. The system combines brain‑computer interface sensors, AI‑driven signal...
MyBrainCo Partners Pharmacy Veteran to Gain Ground in New Sales Channel
Australian nutraceutical brand myBrainCo has partnered with StirlingFildes Plus, a 90‑year‑old pharmacy solutions provider, to accelerate entry into the pharmacy channel. The partnership gives myBrainCo access to StirlingFildes’ network of roughly 5,000 pharmacies, far exceeding the reach of traditional wholesalers like...
GSK Singapore Launches National Shingles Awareness Campaign “Wait For What?”
GlaxoSmithKline Singapore, together with Klick Health, has launched a national shingles awareness campaign titled “Wait For What?” that runs from March through June 2026. The multilingual effort features local celebrities Chen Shu Cheng, Richard Low and Zhu Hou Ren and spans TV, radio, digital, out‑of‑home and healthcare...
FDA Grants Breakthrough Therapy Designation to TERN-701 for Relapsed Ph+ CML
The FDA has awarded breakthrough therapy designation to TERN-701, Terns Pharmaceuticals’ oral BCR::ABL1 inhibitor, for adults with Philadelphia chromosome‑positive chronic myeloid leukemia who have failed at least two prior tyrosine kinase inhibitors. The decision follows phase 1/2 CARDINAL data showing...
MHRA Develops Adaptive AI Framework to Accelerate NHS Clinical Deployments
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) is drafting a new regulatory framework for adaptive artificial‑intelligence tools that evolve with real‑world data. The guidance, focused on lifecycle oversight, seeks to streamline NHS adoption while ensuring continuous safety, performance and...
Noninvasive Skull Sensor Prevents Brain Injuries in Critically Ill ICU Patients
A Brazilian startup, brain4care, has validated a non‑invasive skull sensor that monitors intracranial compliance in real time. In a five‑year study of critically ill neuro‑ICU patients, adding the sensor to standard guideline‑based care cut mortality from 37.3% to 5.9% and...
UnitedHealthcare CEO Unveils $20‑Million CRC Initiative to Boost Customer Satisfaction
UnitedHealthcare chief executive Drew Anthony Smith announced a consumer‑incident resolution program that has already served 150,000 members, raised satisfaction scores to 8.8 out of 10 and generated $20‑25 million in cost savings. The rollout, built on AI and a 330‑person team,...
10x Genomics Unveils A
I've been watching spatial biology for years. What @10xGenomics just announced changes the game. Serge Saxonov, CEO and Co-founder, 10x Genomics told Synbiobeta, "Biology is inherently complex, and as much progress as we have made, we still understand only a...
AstraZeneca's Bretzi Inhaler Cleared for Asthma in Teens
#AZN Bretzi inhaler approved by US FDA for treating patients 12 years old and upwards for Asthma, following the KALOS and LOGOS Phase III trials. Previously got COPD approval.
Merck Beats EPS Forecast but Revenue Misses, Shares Slide 3.7% Pre‑Market
Merck & Co. reported Q2 2025 earnings that topped expectations on earnings per share, delivering $2.13 versus the $2.03 consensus. Revenue, however, slipped to $15.8 billion, missing the $15.87 billion outlook and prompting a 3.67% drop in the stock during pre‑market trading....
Morgan Stanley Flags IL‑23 Combos, Seeks Novel MOAs
Immunology combination studies from Morgan Stanley ahead of DUET data next week. These are mainly coformulations of established drugs, it would be more intriguing to see novel MOAs added to an IL23 backbone. https://t.co/dde8MpBhUR
Enhanced Exosomes Modulate OA Inflammatory Microenvironment
The role of exosomes and their enhancement strategies in the treatment of osteoarthritis "This article provides a comprehensive review and update on the research of exosomes, a type of extracellular vesicle, in the treatment of OA by modulating the inflammatory microenvironment..." https://t.co/xHjTCixJNE
Strong Policies Required As Sugar Fuels Oral Health Crisis
The New Zealand Dental Association (NZDA) is urging the government to adopt stronger sugar‑reduction policies, warning that the current food environment fuels preventable oral disease, obesity and diabetes. It cites the WHO’s finding that 116 countries now tax sugary drinks...
CEO of For-Profit MA Plan Tells CMS “Pay Us Less”
Devoted Health CEO Ed Park told CMS at the Medicarians conference that the for‑profit Medicare Advantage (MA) plan would welcome lower government payments. He cited MedPAC’s March report showing MA enrollees cost the federal government $76 billion more than traditional Medicare....
Traditional MDs Now Seeking Peptide Knowledge for Joint Health
So many of my “conventional” (not in the health and wellness space or even online much) MD friends are asking about peptides to 1) get educated (patients are asking them about peptides) 2) they want to know if BPC can help their...
What If Endometriosis Is Not Just Hormonal? Scientists Are Looking at Bacteria
Endometriosis, long explained by retrograde menstruation, is now being re‑examined through a bacterial lens. A 2023 iScience review highlights that 64% of patients harbor Fusobacterium in the endometrium, suggesting microbes may trigger inflammation via LPS‑TLR4 signaling and facilitate lesion formation....
Asgard Therapeutics to Unveil AT‑108 Gene Therapy Data at ASGCT 2026
Asgard Therapeutics announced that it will present advanced preclinical data on AT‑108, its first‑in‑class off‑the‑shelf gene‑based cancer immunotherapy, at the ASGCT Annual Meeting in Boston (May 11‑15, 2026). The study shows systemic anti‑tumor immunity, an abscopal effect, and identifies dosing...
How Big Is Organon’s Biosimilar Push for Sun Pharma?
Sun Pharma’s $11.75 billion acquisition of Organon propels the Indian drugmaker into the global biosimilars market, placing it among the top ten players. Organon’s biosimilar portfolio generated $691 million in 2025, about 11 % of its total revenue, with 45 % of that coming...
Bacteria-Resistant Coating on Catheters Reduces Infection and Need for Antibiotics
A clinical trial of Camstent's bacteria‑resistant polymer‑coated catheter showed a one‑third drop in catheter‑associated urinary tract infections (CAUTIs) and more than a 50 % reduction in antibiotic use versus standard catheters. Long‑term patients using the coated device reported zero symptomatic CAUTIs...
AxoGen Inc (AXGN) Q1 2026 Earnings Call Transcript
Axogen reported Q2 2025 revenue of $56.7 million, an 18.3% year‑over‑year increase, and posted a modest net profit of $0.6 million, turning quarterly profitability. Gross margin rose to 74.2% and operating expenses fell as a share of revenue, highlighting operating leverage. The...